Moreover, ROC curve analysis showed that TAF12 expression could predict 3- and 5-year survival of glioma patients with AUC values >0.7, which supports the use of TAF12 expression as a novel predictor of survival in glioma. This evidence concerns the gene TAF12 and glioma.